drugset / Trial / NCT06416969
Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation
Phase 0
Recruiting
24 enrolled
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
Non-randomizedParallel-groupOpen-labelBasic science
Summary
Adults who gain most of their excess weight in the abdominal area typically do not respond to factors that "turn on" fat cells the same way as people who don't have excessive weight. Researchers are trying to understand why fat tissue responds differently in people with different body types.
Timeline
- Start
- 2024-01-01
- Primary completion
- 2028-01-01
- Completion
- 2028-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epinephrine | Other / unclassified | — | Intravenous |
| Subject | Somatostatin | Traditional medicine (herbal / TCM) | 200 ug | Intravenous |